Invention Grant
- Patent Title: Compositions and methods for treating HCV
-
Application No.: US15398390Application Date: 2017-01-04
-
Publication No.: US10201541B1Publication Date: 2019-02-12
- Inventor: Christine A. Collins , Daniel E. Cohen , Gennadiy Koev , Preethi Krishnan , Tami J. Pilot-Matias
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: ABBVIE INC.
- Current Assignee: ABBVIE INC.
- Current Assignee Address: US IL North Chicago
- Agency: Neal, Gerber & Eisenberg LLP
- Main IPC: A01N37/18
- IPC: A01N37/18 ; A61K38/00 ; A61K31/33 ; A61K31/00 ; A61K31/505 ; A61K31/435 ; A61K31/44 ; A61K31/41 ; A61K31/40 ; A61K31/27 ; A61K31/16 ; A01N43/00 ; A01N43/58 ; A01N43/54 ; A01N43/40 ; A01N43/42 ; A01N43/64 ; A01N47/10 ; A01N41/02 ; C07D471/04 ; C07D471/22 ; C07D487/04 ; A61P1/16 ; A61K31/513 ; A61K31/4025 ; A61K45/06 ; A61K38/05
Abstract:
This disclosure is directed to pharmaceutical compositions that comprise two or more therapeutic agents that, inter alia, are useful for inhibiting hepatitis C virus (HCV) and methods for inhibiting HCV by co-administering two or more anti-HCV therapeutic agents.
Information query
IPC分类:
